These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33475968)

  • 41. Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis.
    Ishikawa N; Imamura T; Nakajima K; Yamaga J; Yuchi H; Ootsuka M; Inatsu H; Aoki T; Eto T
    Intern Med; 2001 Sep; 40(9):901-4. PubMed ID: 11579953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spray dried formulation of mesalamine embedded with probiotic biomass for the treatment of ulcerative colitis:
    Thakur V; Singh A; Joshi N; Mishra N
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1807-1820. PubMed ID: 31489829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesalamine-induced granulomatous hepatitis.
    Braun M; Fraser GM; Kunin M; Salamon F; Tur-Kaspa R
    Am J Gastroenterol; 1999 Jul; 94(7):1973-4. PubMed ID: 10406274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interstitial nephritis after treatment with mesalazine in the patient with ulcerative colitis].
    Maeda S; Nomura S; Tahara M; Haneda M; Kikkawa R
    Nihon Naika Gakkai Zasshi; 2001 May; 90(5):872-3. PubMed ID: 11460356
    [No Abstract]   [Full Text] [Related]  

  • 45. Exacerbation of chronic ulcerative colitis with mesalamine.
    Sturgeon JB; Bhatia P; Hermens D; Miner PB
    Gastroenterology; 1995 Jun; 108(6):1889-93. PubMed ID: 7768395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Latushko A; Ghazi LJ
    Dig Dis Sci; 2016 Dec; 61(12):3633-3634. PubMed ID: 27766449
    [No Abstract]   [Full Text] [Related]  

  • 47. [Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].
    Inatsuchi S; Nakajima T; Yoshio Y; Entani A; Okada K
    Nihon Shokakibyo Gakkai Zasshi; 2004 Sep; 101(9):989-92. PubMed ID: 15478662
    [No Abstract]   [Full Text] [Related]  

  • 48. First report of mesalamine (5-aminosalicylic acid) as the causative agent in a case of acute generalized exanthamous pustulosis.
    Rocci E; Park K; Hutchens K; Winterfield L
    Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity Reactions.
    Hirono H; Watanabe K; Hasegawa K; Honma T; Ajioka Y; Ohkoshi S
    Am J Case Rep; 2018 May; 19():623-629. PubMed ID: 29849018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis.
    Kanazawa M; Tominaga K; Kanamori A; Tanaka T; Masuyama S; Watanabe S; Abe K; Yamamiya A; Goda K; Irisawa A
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thrombopenia in treatment with mesalazine].
    Seror P
    Presse Med; 2000 Sep; 29(27):1510-1. PubMed ID: 11045119
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiac MRI-confirmed mesalamine-induced myocarditis.
    Baker WL; Saulsberry WJ; Elliott K; Parker MW
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26341161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Respiratory distress during mesalamine therapy.
    Guslandi M
    Dig Dis Sci; 1999 Jan; 44(1):48-9. PubMed ID: 9952222
    [No Abstract]   [Full Text] [Related]  

  • 55. How important is mesalamine in the maintenance of steroid-refractory colitis?
    Actis GC; Marzano A; Pellicano R; Rizzetto M
    Inflamm Bowel Dis; 2008 Jul; 14(7):1026. PubMed ID: 18338772
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

  • 57. Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.
    Boyle M; Ting A; Cury DB; Nanda K; Cheifetz AS; Moss A
    Inflamm Bowel Dis; 2015 Dec; 21(12):2873-8. PubMed ID: 26313693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.
    Herfarth H; Tjaden C; Lukas M; Obermeier F; Dilger K; Müller R; Schölmerich J;
    Gut; 2006 Oct; 55(10):1525-6. PubMed ID: 16966711
    [No Abstract]   [Full Text] [Related]  

  • 59. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
    Fleming K; Ashcroft A; Alexakis C; Tzias D; Groves C; Poullis A
    World J Gastroenterol; 2015 Mar; 21(11):3376-9. PubMed ID: 25805947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
    Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B
    Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.